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Background: External cephalic version (ECV) is infrequently performed and 98% of breech presenting fetuses are
delivered surgically. Neuraxial analgesia can increase the success rate of ECV significantly, potentially reducing
cesarean delivery rates for breech presentation. The current study aims to determine whether the additional cost to
the hospital of spinal anesthesia for ECV is offset by cost savings generated by reduced cesarean delivery.
Methods: In our tertiary hospital, three variables manpower, disposables, and fixed costs were calculated for ECV,
ECV plus anesthetic doses of spinal block, vaginal delivery and cesarean delivery. Total procedure costs were
compared for possible delivery pathways. Manpower data were obtained from management payroll, fixed costs by
calculating cost/lifetime usage rate and disposables were micro-costed in 2008, expressed in 2013 NIS.
Results: Cesarean delivery is the most expensive option, 11670.54 NIS and vaginal delivery following successful ECV
under spinal block costs 5497.2 NIS. ECV alone costs 960.21 NIS, ECV plus spinal anesthesia costs 1386.97 NIS. The
highest individual cost items for vaginal, cesarean delivery and ECV were for manpower. Expensive fixed costs for
cesarean delivery included operating room trays and postnatal hospitalization (minimum 3 days). ECV with spinal
block is cheaper due to lower expected cesarean delivery rate and its lower associated costs.
Conclusions: The additional cost of the spinal anesthesia is offset by increased success rates for the ECV procedure
resulting in reduction in the cesarean delivery rate.
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Cesarean delivery is recommended by national guidelines
for the breech presenting fetus (3-4% of pregnancies) [1,2].
These same national guidelines recommend the availability
of an external cephalic version (ECV) service; potentially
enabling attempted vaginal delivery. Unfortunately, ECV is
infrequently performed, hence 98% of breech presentations
are delivered surgically [3,4]. Potential reasons for poor
uptake of ECV include low ECV success rates, lack of* Correspondence: carolynfweiniger@gmail.com
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reproduction in any medium, provided the orphysician referral and unwillingness of patients to undergo
the procedure [3,5,6].
Immediate hospital and health fund costs of cesarean
delivery are higher than vaginal delivery [7,8]. A computer-
based model of ECV trial versus scheduled cesarean
delivery found that ECV is cost-effective above a success
threshold of 32% [7]. Addition of neuraxial blockade for
ECV generates a hospital cost benefit if the ECV success
rate is increased 11% above a baseline of 38% without neur-
axial blockade [9]. However the study showing these data
combined anesthetic (increased ECV success rate) and anal-
gesic (little effect on ECV success) doses in their analysis;
potentially muting the findings.
In ideal circumstances, vaginal delivery of a cephalic pres-
entation is the safest route for both mother and neonateal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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of ECV are maximally high; for example through use of
neuraxial blockade [12-14].
The current study aims to determine whether the add-
itional cost to the hospital of spinal anesthesia is offset by
increased success rates for the ECV procedure; through de-
creased cesarean delivery rates.
Methods
The study was carried out in a tertiary hospital in the Labor
and Delivery suite using financial data obtained from 2008
in New Israeli Shekels (NIS) and costs were adjusted to
2013 NIS using the consumer price index. The conversion
factor used is 1.3336229. We present the costs to the hos-
pital. Fixed equipment costs were calculated as a unit cost
for the expected lifetime of the item. The fixed costs, for
expenses such as hospital bed and multi-use equipment
(blood pressure monitor, fetal heart rate monitor, and ultra-
sound) were calculated as a 20% overhead according to the
accepted Israeli Ministry of Health method. Disposables in-
clude gloves, spinal needles, drugs, and sterile pack for per-
forming anesthesia of surgery. Personnel include costs of all
the staff (obstetricians, midwives and anesthesiologists) in-
volved in each procedure: vaginal delivery, cesarean delivery
and ECV with and without spinal anesthesia. Ethical ap-
proval was not required for this cost analysis study.
Current practice for management of breech presenta-
tion in our institution comprises performing ECV, or
elective cesarean delivery. In the case of successful ECV -
vaginal delivery may be attempted.
We systematically searched Cochrane, Medline and
Web of Science databases from 1990 to January 2013
using key words; “breech; external cephalic version;
ECV; anesthesia; analgesia; spinal; epidural; neuraxial;
version; fetal”. We excluded manuscripts based upon
title and abstract content. We manually searched the
bibliography of relevant manuscripts. Using this search
strategy we identified 6 randomized controlled trial pub-
lications using neuraxial blockade (comprising analgesia
or anesthesia doses) for ECV and 3 cost analyses, and
used these data to calculate our probability of ECV suc-
cess with spinal anesthesia and delivery outcomes
[7-9,15-20].
Data analysis
For each delivery management pathway the individual
itemized costs for each major variable (fixed costs, dis-
posables, and manpower) were entered as a separate
item into an Excel worksheet (Microsoft Office 2000).
Thus each delivery management pathway (vaginal deliv-
ery, cesarean delivery, spinal anesthesia) is presented as
a unit total cost.
We pooled data from our two randomized controlled tri-
als with an overall success rate of 76.1% for ECV usingspinal anesthesia versus 44.8% ECV success rate without
anesthesia – obtained from 134 enrolled patients (64 multi-
paras and 70 nulliparas) [19,20]. For our model, we used a
vaginal delivery rate derived from the total rate of vaginal
cephalic delivery following successful ECV in our pooled
study population: 68 successful cephalic vaginal deliveries
from 81 successful ECVs (84%). Thus 16% of successful
ECV underwent cesarean delivery. This cesarean delivery
rate was within the range reported among 206,909 deliver-
ies between 2002–2008; the cesarean delivery rate for ceph-
alic presentation intrapartum was 12.8%, and for attempted
vaginal delivery after labor induction was 21.1%. Other
studies reported a cesarean delivery rate after successful
ECV of 16-26% [21,22].
Confidence intervals were calculated for the manage-
ment pathways rates for cesarean and vaginal delivery
using WinPepi version 11.15; using sample sizes from
the derivation data [19,20].
Results
Among 150,000 deliveries per year in Israel, up to 4% are
breech presentation – 6000 breech deliveries/year. In the
case that 76% of ECV performed are successful using spinal
anesthesia this would result in 4,560 potential vaginal deliv-
eries. Of these, 16% may undergo cesarean, but 3830 (84%)
additional vaginal deliveries may occur.
The sum of the number of items and the costs per
possible procedure performed are reported in Table 1.
Cesarean delivery is the most expensive option, 11670.54
NIS, and vaginal delivery costs 4110.23 NIS. Successful
ECV under spinal anesthesia with subsequent vaginal
delivery costs 5497.2 NIS. Addition of spinal anesthesia
for the ECV procedure costs 426.76 NIS. Using the costs
presented in Table 1, maximum savings can be calcu-
lated: 8,321,820 NIS for spinal anesthesia for ECV of
6000 breech presentation cases, in addition to the deliv-
ery costs (3830 vaginal deliveries = 15,742, 181 NIS and
2170 cesarean deliveries = 25, 325, 072 NIS) generating a
total costs of 49, 389, 07 NIS. If all 6000 breech presen-
tations were delivered by cesarean delivery without
spinal anesthesia, the cost is 70, 023 240 NIS, generating
a maximum possible saving of 20, 634, 167 NIS nation-
ally in Israel per year.
The highest individual costs were for manpower for
vaginal delivery, cesarean delivery and ECV. It was cal-
culated that nursing care hours required were 14 per va-
ginal delivery, 4 per ECV procedure, 5.5 for cesarean
delivery and physician hours would be 1.5, 2, and 3.5 for
vaginal delivery, ECV and cesarean delivery, respectively.
Expensive fixed costs for cesarean delivery include oper-
ating room trays and postnatal hospitalization (mini-
mum 3 days).
Six randomized controlled trials (RCTs) report success
rates for ECV, using neuraxial blockade compared to









No. items total per procedure Procedure
11670.54 4076.89 1298.95 6294.70 77 Cesarean delivery
4110.23 1824.40 250.72 2035.11 39 Vaginal delivery
960.21 533.45 17.34 409.42 10 ECV
1386.97 808.18 169.37 409.42 18 ECV plus Spinal block
Key: Costs sourced in 2008 were adjusted to 2013 NIS price levels using the consumer price index. The conversion factor used is 1.3336229. (Central Bureau of
Statistics, Price Statistics Monthly - September 2013. Jerusalem). Costs were sourced from hospital budget itemizations.
ECV = external cephalic version, NIS = New Israeli Shekel.
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were retrieved from our previous studies for vaginal and
cesarean delivery (combined multiparas and nulliparas)
[19,20]. Previous RCTs using anesthesia for successful
ECV reported a combined cesarean delivery rate of
16.3% [15,16,19,20]. When analgesia, rather than
anesthesia is considered for ECV, successful cases have a
reported cesarean delivery rate of 14% [17,18]. Table 3 is
based upon the pathway rates presented in Figure 1. The
costs associated with breech delivery are reduced as
ECV success increases across a range of rates, and costs
are additionally dependent on the cesarean delivery rate
following successful ECV, Figure 2a and b.
Discussion
In the current study we found that complications and
quality of life considerations aside, adoption of policy of
ECV with spinal anesthesia engenders hospital cost saving
benefit through increased ECV success rates and subse-
quent decreased cesarean deliveries. The hospital cost of
426.76 NIS per anesthetic for ECV generates a cost saving
of 1761.27 through decreased cesarean delivery - if the va-
ginal delivery rate following successful ECV is 84%. For
the 6,000 annual breech presenting births in Israel, this
could save the hospital providers over 20 million NIS per
year if ECV were performed under anesthesia for all
breech presentation, and if ECV is maximally successful
and cesarean delivery rates are minimal.Table 2 Vaginal delivery rates following ECV with neuraxial b
dose) in previously published randomized trials




Dugoff [22] Analgesia 22/50 (44%) 22/52
Mancuso [20] Anesthesia 32/54 (59%) 18/54
Schorr [19] Anesthesia 24/35 (69%) 11/34
Sullivan [21] Analgesia 22/47 (47%) 15/48
Weiniger [16] Anesthesia 24/36 (67%) 11/34
Weiniger [15] Anesthesia 27/31 (87%) 19/33
adata presented are vaginal cephalic delivery only.
Effect size = ECV success rate.
bexcludes vaginal breech delivery and repeat ECV.
‡Following unsuccessful ECV five patients overall had spontaneous version to cephaSeveral studies report that adopting a policy of ECV
for the breech presenting fetus could result in a signifi-
cant cost saving, in particular when neuraxial blockade
is used [7-9]. Previously reported success rates of ECV,
range from 30-70% [23,24]. The current study considers
ECV performed using spinal anesthesia, which signifi-
cantly increases the ECV success rate to over 67%. The
success rates from ECV with neuraxial blockade vary con-
siderably depending on whether an anesthetic or analgesic
dose was used. Carvalho et al., demonstrated cost benefit
for ECV using a combination of data from anesthesia and
analgesia studies despite the latter being less effective at
influencing ECV success rates [9]. Anesthetic rather than
analgesia doses are more effective [25].
The ultimate aim of ECV is to reduce the cesarean de-
livery rates; breech cesarean delivery accounts for 25% of
elective cases [26]. Following one cesarean delivery for
breech presentation, subsequent cesarean delivery is ex-
pected in 90% of cases [27]. We calculated data based
upon a 16% cesarean delivery rate following ECV suc-
cess. Other studies report a wide range of cesarean deliv-
ery rates following successful ECV, from 16.4-50%
[21,28-31]. A lower overall cesarean delivery rate in a
specific population undergoing vaginal delivery generates
greater potential cost benefit using neuraxial block for
ECV. Spinal anesthesia has a greater effect on the base
case cost over the range of possible ECV success rates







(42%) 16/50‡ (32.0%) 25/52‡ (48.1%)
(33.3%) 28/54a (51.9%) 13/54a (24.1%)
(32.4%) 23/35 (65.7%) 7/34 (20.6%)
(31.3%) 17/47 (36.2%) 12/48 (25%)
(32.4%) 16/36 (44.4%) 8/34 (23.5%)
(57.6%) 25/31b (80.%) 19/33b (57.6%)
lic presentation with vaginal delivery.
Figure 1 Potential delivery pathways for the base case patient with breech presenting fetus. The patient with breech presenting fetus can
go directly to cesarean delivery, or undergo ECV, either with (Pathway B) or without (Pathway C) spinal anesthesia. ECV success rates with and
without spinal anesthesia were taken from our previous publications [19,20]. Pathway A (no ECV) shows 100% CD rate, despite the possibility of
vaginal breech delivery or spontaneous conversion to cephalic presentation. For pathways B2/B3 and C2/C3, following successful ECV, a cesarean
delivery rate of 16% is used, based upon calculated data from Table 3. Costs associated with each pathway are presented in Table 3. VD = vaginal
delivery, CD = cesarean delivery.
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ential between the ECV success ranges is less
pronounced.
The current study micro-costed the hospital purchas-
ing price of every item involved in the costs of perform-
ing each procedure (fixed, equipment, and personnel).
Hence the actual costs of ECV, spinal block, normal de-










No ECV CD 11670.54 1
T
Pathway B
B1 ECV (failure), CD 12630.75 5
B2 ECV (success), CD 12630.75 7
B3 ECV (success), VD 5070.44 3
T
Pathway
C1 ECV + spinal, CD 13057.51 2
C2 ECV + spinal, CD 13057.51 1
C3 ECV + spinal, VD 5497.2 6
T
Key: Costs are derived from Table 1 unit costs and% of each pathway occurring.
CD = cesarean delivery, VD = vaginal delivery, ECV = external cephalic version, CI = c
Pathway A = no ECV, Pathway B = ECV without spinal anesthesia, Pathway C = ECV w
For CI calculation, the denominator is 67 (Table 3) [19,20].known itemized costs as has been done previously [8,9].
Other previous studies have used national department of
health figures for calculating costs which are based on a
national tariff or reimbursement fees, rather than actual
itemized costs [23,24]. Costs differ greatly among coun-
tries. The cost of ECV in the USA is significantly higher
than in the UK or in our current Israeli study
[7,8,15,32]. The key factor in this cost variance is salaryion tree, Figure 1
D/VD rates after ECV [19,20] Relative
probability (95% CI)
Relative cost NIS (CD rate
16% after successful ECV)
00%



































Sensitivity to ECV (no spinal) success rate
No ECV
ECV, no spinal, CD=16%

























Sensitivity to ECV with spinal success rate
No ECV
ECV, with spinal, CD=16%
ECV, with spinal, CD=30%
a
b
Figure 2 Reported ECV success rates range from 30-70%; higher ECV success generate higher vaginal delivery rates - decreasing costs.
Figure 2a shows ECV success rates ranging from 30-70% without spinal anesthesia and Figure 2b shows ECV success rates ranging from 30-70%
with spinal anesthesia. Both show costs for a 16% and 30% cesarean delivery rate. If the prevailing cesarean delivery rate increases from 16% to
30%, the cost savings from ECV success rates falls.
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the USA reported that ECV with neuraxial block costs
1221$ and without neuraxial block 1087$ in 2010 [9].
This is almost four times the Israeli 2008 costs, however
the same authors reported their ECV cost without neur-
axial block in 2007 was only slightly lower, 1024$. James
et al. in a study from the UK, micro-costed each proced-
ure involved in the ECV pathway, similar to the current
study, and calculated ECV to cost approximately 284$
(1136 NIS), only slightly higher than our local estimate
[8]. Their study reported ECV but without neuraxial
block, which may have significantly increased ECV suc-
cess rates, thus providing a more remarkable cost saving.
A cesarean delivery in the UK was also more expensive
at 2930$ compared with 2500$ in Israel. The UK study
did not factor in the cost of neuraxial block, and the
average ECV success rate was only 50%, less than that
expected with use of spinal anesthesia in the current
study. Since Ministry of Health imposes hospital costs inIsrael, ours may reflect those of other Israeli institutions.
Although ECV is recommended by the American Col-
lege of Obstetrics and Gynecologists (guidelines adopted
in Israel), national ramifications of our study findings
should consider that ECV practice may differ among in-
stitutions, as do cesarean rates.
A further cost consideration in the US is actual re-
imbursement to the hospital. The low USA reimbursement
costs calculated on Relative Value Units (RVUs) for ECV
(1.71) compared with cesarean delivery (16.33) may not en-
courage practice [34]. Personnel costs are considerably
higher in the US compared with UK and Israel, albeit data
for the UK are from 1997 [8,9]. Attempts to favor vaginal
delivery through reimbursement have not curtailed the in-
crease in cesarean delivery [4]. Hospital costs may be higher
or lower than actual reimbursement costs, depending on
how the hospital calculates their actual ECV costs.
Another important factor to consider is quality ad-
justed life years (QALYs) resulting from a particular
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cesarean delivery include maternal wound infection and
duration of disability from surgical scar. Following
normal vaginal delivery, relevant QALYS include immo-
bility following perineal tears. The current study did not
consider sufficient patients to calculate QALYs. However
previous data suggest that normal vaginal delivery is less
costly in terms of QALYs than cesarean delivery [7].
The data we present focus on hospital savings and ignore
other potential costs benefits to the patient, family or health
fund. The success rates of ECV under neuraxial block may
differ between institutions, which would impact the savings
found [21,26,30]. Any hospital wishing to calculate personal
cost savings would need to make calculations based on
their own ECV success and cesarean rates. Hospital stay,
hence costs, are longer following cesarean and we did not
calculate this benefit. Furthermore, cost of emergency
cesarean delivery and the impact of spontaneous version
were not calculated. Some women may refuse ECV, despite
the possibility that ECV may be successful and allow them
a vaginal delivery, or may have contraindications. Imple-
mentation of a formal decision management plan may in-
crease ECV uptake [5]. Overheads (lighting, administration)
are usually considered fixed costs and not itemized. Costs
are calculated locally, and the overhead of 20% used in
Israel may differ in other countries.
Conclusions
Performing ECV using spinal anesthesia results in large
cost savings to the hospital overall, since the rate of
cesarean delivery can be reduced. The potential savings in
other countries, where unit procedure (specifically man-
power) costs are higher, may be larger than those in Israel.
Protocols for advising patients of the benefits of ECV, and
the additional benefits of anesthesia should be imple-
mented. Both the patient and the hospital stand to gain
financially and otherwise from successful ECV with subse-
quent vaginal delivery.
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